Mariner’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,170
Closed -$37.4K 3401
2024
Q3
$37.4K Sell
1,170
-332
-22% -$18.4K ﹤0.01% 3218
2024
Q2
$123K Buy
+1,502
New +$162K ﹤0.01% 2912
2024
Q1
Sell
-1,522
Closed -$140K 3148
2023
Q4
$140K Sell
1,522
-101
-6% -$10.3K ﹤0.01% 2788
2023
Q3
$268K Buy
+1,623
New +$211K ﹤0.01% 2260

Other funds holding CDLX

Mariner's CDLX Position: Q4 2024 in Review

Mariner sold out of Cardlytics (CDLX) in Q4 2024, closing a stake of 1,170 shares — an estimated $37.4K sold.

Mariner first reported a position in CDLX in Q3 2023 and held it in 4 quarters. The position peaked at $268K in Q3 2023. 108 funds tracked by Wall St. Rank hold CDLX as of Q4 2024.

  • Mariner reported no remaining Cardlytics position as of Q4 2024 after selling out during the quarter.
  • Mariner sold 1,170 Cardlytics shares in Q4 2024, an estimated $37.4K.
  • Mariner first reported a position in Cardlytics in Q3 2023 and held it in 4 quarters.
  • Mariner's Cardlytics position peaked at $268K in Q3 2023.
  • 108 funds tracked by Wall St. Rank held Cardlytics as of Q4 2024.

Based on Mariner's 13F filing for Q4 2024, filed 13 Feb 2025.